2013 Report on the International Epigenetics Technology Market - World Forecasts to 2017
(M2 PressWIRE Via Acquire Media NewsEdge) Dublin - Research and Markets (http://www.researchandmarkets.com/research/27bx7t/epigenetics) has announced the addition of the "2013 Report on the International Epigenetics Technology Market - World Forecasts to 2017" report to their offering.
This technology report categorizes the market for epigenetics by geographical region (including the important countries in each region), applications, and epigenetic mechanisms, forecasting the market value in revenue by analyzing the current and future trends in research, diagnostics and therapeutics industries.
A detailed description of the global technology developments and evolving trends in the epigenetics field with key prominence on research innovations, collaborative efforts and focused research through consortiums dedicated for epigenetics.
A close view on the drug development for treatment of various diseases by providing the details and status of current epigenetic drugs in pipeline. An impact analysis of major drivers, restraints and challenges influencing the adoption and growth of epigenetics market during the period from 2012 to 2017.
Market size - Global market forecast for 2012-2017, including demand side analysis and strategic recommendations for technology/product developers. Competitive landscape based on the analysis of key patents and research publications that gives an insight into prominent activities and global participants.
Key Topics Covered:
2. Executive Summary
3. Epigenetics - Technology Landscape Analysis
4. Epigenetics - Market Landscape Analysis
5. Technology Investment Potential
6. Epigenetics - Technology Adoption Potential And Development By Geography
7. Epigenetics Competitive Landscape
8. Intellectual Property And Research Strength Analysis
9. Analyst Insights And Recommendations
10. Company Profiles
- 4Sc (Germany)
- Celgene (U.S.)
- Cellcentric (U.K.)
- Ch3 Biosystems (U.S.)
- Covaris Inc. (U.S.)
- Eisai Co. Ltd. (Japan)
- Epiontis (Germany)
- Epitherapeutics (Denmark)
- Epizyme (U.S.)
- Karus Therapeutics (U.K.)
- Merck Millipore (U.S.)
- Ribomed Biotechnologies (U.S.)
For more information visit http://www.researchandmarkets.com/research/27bx7t/epigenetics
Research and Markets,
Fax from USA: 646-607-1907
Fax from rest of the world: +353-1-481-1716
Sector: Pharmaceuticals (http://www.researchandmarkets.com/categories.asp?cat_id=16&campaign_id=27bx7t)
((M2 Communications disclaims all liability for information provided within M2 PressWIRE. Data supplied by named party/parties. Further information on M2 PressWIRE can be obtained at http://www.presswire.com on the world wide web. Inquiries to firstname.lastname@example.org)).
(c) 2014 M2 COMMUNICATIONS
[ Back To TMCnet.com's Homepage ]